Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma [Corrigendum]
Due to an error that occurred inadvertently at the time of figure assembly, Figure 1B was a duplicate of Figure 2B.The correct Figure 1 is shown below.
Authors
- Chien-Huai Chuang
- Ching-Tso Chen
- Yu-Yun Shao
- Chih-Hung Hsu
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2026-03-01
- DOI
- https://doi.org/10.2147/jhc.s611160
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00